Leptin production in adipocytes from morbidly obese subjects

Stimulation by dexamethasone, inhibition with troglitazone, and influence of gender

Lloyd B. Williams, Rachael L. Fawcett, Angela S. Waechter, Peili Zhang, Brian E. Kogon, RoseMarie Jones, Margaret Inman, John Huse, Robert Considine

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

This study examined the regulation of leptin production by dexamethasone and troglitazone. Subcutaneous and omental adipose tissue was obtained during bariatric surgical procedures (30 women and 16 men; body mass index, 52.5 ± 1.7 kg/m2, age, 39± 2 yr), and adipocytes were cultured in suspension. Subcutaneous adipocytes from females released significantly more leptin than did omental cells from the same subject (P < 0.05), but basal leptin release was not different in adipocytes from these depots in males. Dexamethasone (0.1 μmol/L) significantly increased leptin release within 24 h from sc (135 ± 13% of control) and omental (227 ± 53%) adipocytes of females, but not males. Dexamethasone-stimulated leptin production at 48 h was significantly greater in the omental adipocytes of females (398 ± 64% of control) than in sc adipocytes of females (207 ± 21%) or the omental (211 ± 33%) and sc (180 ± 23%) adipocytes of males. Troglitazone (10 μmol/L; 48 h) significantly inhibited dexamethasone-stimulated leptin release in sc (57 ± 10.7% inhibition) and omental adipocytes (134 ± 26% inhibition). There was no gender-related difference in the effect of troglitazone to inhibit dexamethasone-stimulated leptin release. Troglitazone significantly inhibited basal leptin production from omental adipocytes by 15.0 ± 5.2%. The effect of dexamethasone and troglitazone to regulate leptin release was mediated through changes in ob gene expression, but did not involve changes in glucose uptake or metabolism to lactate. The data suggest that adipocytes from females are more responsive to the stimulatory effect of dexamethasone in vitro than are adipocytes from males. If adipocytes from females are more responsive to relevant in vivo stimuli for leptin secretion such as insulin or glucose, this could contribute to the gender difference in serum leptin. The data also suggest that leptin release from omental adipocytes may be more responsive to hormonal and nutrient regulation in vivo than are sc adipocytes.

Original languageEnglish
Pages (from-to)2678-2684
Number of pages7
JournalJournal of Clinical Endocrinology and Metabolism
Volume85
Issue number8
DOIs
StatePublished - 2000

Fingerprint

troglitazone
Leptin
Adipocytes
Dexamethasone

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

Leptin production in adipocytes from morbidly obese subjects : Stimulation by dexamethasone, inhibition with troglitazone, and influence of gender. / Williams, Lloyd B.; Fawcett, Rachael L.; Waechter, Angela S.; Zhang, Peili; Kogon, Brian E.; Jones, RoseMarie; Inman, Margaret; Huse, John; Considine, Robert.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 85, No. 8, 2000, p. 2678-2684.

Research output: Contribution to journalArticle

Williams, Lloyd B. ; Fawcett, Rachael L. ; Waechter, Angela S. ; Zhang, Peili ; Kogon, Brian E. ; Jones, RoseMarie ; Inman, Margaret ; Huse, John ; Considine, Robert. / Leptin production in adipocytes from morbidly obese subjects : Stimulation by dexamethasone, inhibition with troglitazone, and influence of gender. In: Journal of Clinical Endocrinology and Metabolism. 2000 ; Vol. 85, No. 8. pp. 2678-2684.
@article{2adcb09abb8c4cc2bb01cdbdd1a3a5df,
title = "Leptin production in adipocytes from morbidly obese subjects: Stimulation by dexamethasone, inhibition with troglitazone, and influence of gender",
abstract = "This study examined the regulation of leptin production by dexamethasone and troglitazone. Subcutaneous and omental adipose tissue was obtained during bariatric surgical procedures (30 women and 16 men; body mass index, 52.5 ± 1.7 kg/m2, age, 39± 2 yr), and adipocytes were cultured in suspension. Subcutaneous adipocytes from females released significantly more leptin than did omental cells from the same subject (P < 0.05), but basal leptin release was not different in adipocytes from these depots in males. Dexamethasone (0.1 μmol/L) significantly increased leptin release within 24 h from sc (135 ± 13{\%} of control) and omental (227 ± 53{\%}) adipocytes of females, but not males. Dexamethasone-stimulated leptin production at 48 h was significantly greater in the omental adipocytes of females (398 ± 64{\%} of control) than in sc adipocytes of females (207 ± 21{\%}) or the omental (211 ± 33{\%}) and sc (180 ± 23{\%}) adipocytes of males. Troglitazone (10 μmol/L; 48 h) significantly inhibited dexamethasone-stimulated leptin release in sc (57 ± 10.7{\%} inhibition) and omental adipocytes (134 ± 26{\%} inhibition). There was no gender-related difference in the effect of troglitazone to inhibit dexamethasone-stimulated leptin release. Troglitazone significantly inhibited basal leptin production from omental adipocytes by 15.0 ± 5.2{\%}. The effect of dexamethasone and troglitazone to regulate leptin release was mediated through changes in ob gene expression, but did not involve changes in glucose uptake or metabolism to lactate. The data suggest that adipocytes from females are more responsive to the stimulatory effect of dexamethasone in vitro than are adipocytes from males. If adipocytes from females are more responsive to relevant in vivo stimuli for leptin secretion such as insulin or glucose, this could contribute to the gender difference in serum leptin. The data also suggest that leptin release from omental adipocytes may be more responsive to hormonal and nutrient regulation in vivo than are sc adipocytes.",
author = "Williams, {Lloyd B.} and Fawcett, {Rachael L.} and Waechter, {Angela S.} and Peili Zhang and Kogon, {Brian E.} and RoseMarie Jones and Margaret Inman and John Huse and Robert Considine",
year = "2000",
doi = "10.1210/jc.85.8.2678",
language = "English",
volume = "85",
pages = "2678--2684",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "8",

}

TY - JOUR

T1 - Leptin production in adipocytes from morbidly obese subjects

T2 - Stimulation by dexamethasone, inhibition with troglitazone, and influence of gender

AU - Williams, Lloyd B.

AU - Fawcett, Rachael L.

AU - Waechter, Angela S.

AU - Zhang, Peili

AU - Kogon, Brian E.

AU - Jones, RoseMarie

AU - Inman, Margaret

AU - Huse, John

AU - Considine, Robert

PY - 2000

Y1 - 2000

N2 - This study examined the regulation of leptin production by dexamethasone and troglitazone. Subcutaneous and omental adipose tissue was obtained during bariatric surgical procedures (30 women and 16 men; body mass index, 52.5 ± 1.7 kg/m2, age, 39± 2 yr), and adipocytes were cultured in suspension. Subcutaneous adipocytes from females released significantly more leptin than did omental cells from the same subject (P < 0.05), but basal leptin release was not different in adipocytes from these depots in males. Dexamethasone (0.1 μmol/L) significantly increased leptin release within 24 h from sc (135 ± 13% of control) and omental (227 ± 53%) adipocytes of females, but not males. Dexamethasone-stimulated leptin production at 48 h was significantly greater in the omental adipocytes of females (398 ± 64% of control) than in sc adipocytes of females (207 ± 21%) or the omental (211 ± 33%) and sc (180 ± 23%) adipocytes of males. Troglitazone (10 μmol/L; 48 h) significantly inhibited dexamethasone-stimulated leptin release in sc (57 ± 10.7% inhibition) and omental adipocytes (134 ± 26% inhibition). There was no gender-related difference in the effect of troglitazone to inhibit dexamethasone-stimulated leptin release. Troglitazone significantly inhibited basal leptin production from omental adipocytes by 15.0 ± 5.2%. The effect of dexamethasone and troglitazone to regulate leptin release was mediated through changes in ob gene expression, but did not involve changes in glucose uptake or metabolism to lactate. The data suggest that adipocytes from females are more responsive to the stimulatory effect of dexamethasone in vitro than are adipocytes from males. If adipocytes from females are more responsive to relevant in vivo stimuli for leptin secretion such as insulin or glucose, this could contribute to the gender difference in serum leptin. The data also suggest that leptin release from omental adipocytes may be more responsive to hormonal and nutrient regulation in vivo than are sc adipocytes.

AB - This study examined the regulation of leptin production by dexamethasone and troglitazone. Subcutaneous and omental adipose tissue was obtained during bariatric surgical procedures (30 women and 16 men; body mass index, 52.5 ± 1.7 kg/m2, age, 39± 2 yr), and adipocytes were cultured in suspension. Subcutaneous adipocytes from females released significantly more leptin than did omental cells from the same subject (P < 0.05), but basal leptin release was not different in adipocytes from these depots in males. Dexamethasone (0.1 μmol/L) significantly increased leptin release within 24 h from sc (135 ± 13% of control) and omental (227 ± 53%) adipocytes of females, but not males. Dexamethasone-stimulated leptin production at 48 h was significantly greater in the omental adipocytes of females (398 ± 64% of control) than in sc adipocytes of females (207 ± 21%) or the omental (211 ± 33%) and sc (180 ± 23%) adipocytes of males. Troglitazone (10 μmol/L; 48 h) significantly inhibited dexamethasone-stimulated leptin release in sc (57 ± 10.7% inhibition) and omental adipocytes (134 ± 26% inhibition). There was no gender-related difference in the effect of troglitazone to inhibit dexamethasone-stimulated leptin release. Troglitazone significantly inhibited basal leptin production from omental adipocytes by 15.0 ± 5.2%. The effect of dexamethasone and troglitazone to regulate leptin release was mediated through changes in ob gene expression, but did not involve changes in glucose uptake or metabolism to lactate. The data suggest that adipocytes from females are more responsive to the stimulatory effect of dexamethasone in vitro than are adipocytes from males. If adipocytes from females are more responsive to relevant in vivo stimuli for leptin secretion such as insulin or glucose, this could contribute to the gender difference in serum leptin. The data also suggest that leptin release from omental adipocytes may be more responsive to hormonal and nutrient regulation in vivo than are sc adipocytes.

UR - http://www.scopus.com/inward/record.url?scp=0034455806&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034455806&partnerID=8YFLogxK

U2 - 10.1210/jc.85.8.2678

DO - 10.1210/jc.85.8.2678

M3 - Article

VL - 85

SP - 2678

EP - 2684

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 8

ER -